HomeNDC LookupRxCUI directory › RxCUI 198239

Sulindac 200 MG Oral Tablet — RxCUI 198239

RxNorm drug concept · Semantic clinical drug
RxCUI 198239 Semantic clinical drug · SCD ● Current RxNorm concept 15 FDA products 38 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI198239
Official nameSulindac 200 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped15
Package NDCs mapped38
Reported Medicaid activity (SDUD)52,720 prescriptions · 41 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sulindac: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Sulindac is approved for several painful inflammatory conditions, not just arthritis. It can be used for osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis — which is...
  • What exactly is sulindac used for — is it just for arthritis?
  • Always take sulindac with food. NSAIDs like sulindac can irritate the stomach lining, and taking it with a meal helps reduce that risk. It's taken twice a day in most cases, so pai...
  • Should I take sulindac with food or on an empty stomach?
📖 Read our full Sulindac guide →

🕸️ Concept Web — How Sulindac 200 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sulindac 200 MG Oral Tablet RxCUI 198239

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Sulindac 10237
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sulindac Oral Tablet 374003
    • Sulindac Oral Product 1163018
    • Sulindac Pill 1163019
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Sulindac 200 MG 316756

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sulindac 200 MG SCDC · 316756
  • Sulindac Oral Tablet SCDF · 374003
  • Sulindac Oral Product SCDG · 1163018
  • Sulindac Pill SCDG · 1163019

📦 FDA Products & Package NDCs

15 products · 38 package NDCs
38 package NDCs map to RxCUI 198239 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00591-5660-01 100 TABLET in 1 BOTTLE, PLASTIC (0591-5660-01) Sulindac Actavis Pharma, Inc. 1990-04-03
00591-5660-05 500 TABLET in 1 BOTTLE, PLASTIC (0591-5660-05) Sulindac Actavis Pharma, Inc. 1990-04-03
00591-5661-01 100 TABLET in 1 BOTTLE, PLASTIC (0591-5661-01) Sulindac Actavis Pharma, Inc. 1990-04-03
00591-5661-05 500 TABLET in 1 BOTTLE, PLASTIC (0591-5661-05) Sulindac Actavis Pharma, Inc. 1990-04-03
00904-7334-60 100 TABLET in 1 BOTTLE, PLASTIC (0904-7334-60) SULINDAC Major Pharmaceuticals 2023-07-27
00904-7335-60 100 TABLET in 1 BOTTLE, PLASTIC (0904-7335-60) SULINDAC Major Pharmaceuticals 2023-07-27
24658-0770-01 100 TABLET in 1 BOTTLE (24658-770-01) SULINDAC PuraCap Laboratories LLC dba Blu Pharmaceuticals 2016-11-14
24658-0770-05 500 TABLET in 1 BOTTLE (24658-770-05) SULINDAC PuraCap Laboratories LLC dba Blu Pharmaceuticals 2016-11-14
24658-0771-01 100 TABLET in 1 BOTTLE (24658-771-01) SULINDAC PuraCap Laboratories LLC dba Blu Pharmaceuticals 2016-11-14
24658-0771-05 500 TABLET in 1 BOTTLE (24658-771-05) SULINDAC PuraCap Laboratories LLC dba Blu Pharmaceuticals 2016-11-14
42806-0011-01 100 TABLET in 1 BOTTLE (42806-011-01) SULINDAC Epic Pharma, LLC 2010-01-25
42806-0011-05 500 TABLET in 1 BOTTLE (42806-011-05) SULINDAC Epic Pharma, LLC 2010-01-25
42806-0011-10 1000 TABLET in 1 BOTTLE (42806-011-10) SULINDAC Epic Pharma, LLC 2010-01-25
42806-0018-01 100 TABLET in 1 BOTTLE (42806-018-01) SULINDAC Epic Pharma, LLC 2010-01-25
42806-0018-05 500 TABLET in 1 BOTTLE (42806-018-05) SULINDAC Epic Pharma, LLC 2010-01-25
42806-0018-10 1000 TABLET in 1 BOTTLE (42806-018-10) SULINDAC Epic Pharma, LLC 2010-01-25
50090-0529-04 60 TABLET in 1 BOTTLE (50090-0529-4) SULINDAC A-S Medication Solutions 2016-06-29
50090-2093-04 60 TABLET in 1 BOTTLE (50090-2093-4) SULINDAC A-S Medication Solutions 2015-10-12
53489-0478-01 100 TABLET in 1 BOTTLE, PLASTIC (53489-478-01) SULINDAC Sun Pharmaceutical Industries, Inc. 2009-09-04
53489-0478-02 50 TABLET in 1 BOTTLE, PLASTIC (53489-478-02) SULINDAC Sun Pharmaceutical Industries, Inc. 2009-09-04
53489-0478-03 250 TABLET in 1 BOTTLE, PLASTIC (53489-478-03) SULINDAC Sun Pharmaceutical Industries, Inc. 2009-09-04
53489-0478-05 500 TABLET in 1 BOTTLE, PLASTIC (53489-478-05) SULINDAC Sun Pharmaceutical Industries, Inc. 2009-09-04
53489-0478-06 60 TABLET in 1 BOTTLE, PLASTIC (53489-478-06) SULINDAC Sun Pharmaceutical Industries, Inc. 2009-09-04
53489-0478-10 1000 TABLET in 1 BOTTLE, PLASTIC (53489-478-10) SULINDAC Sun Pharmaceutical Industries, Inc. 2009-09-04
53489-0479-01 100 TABLET in 1 BOTTLE, PLASTIC (53489-479-01) SULINDAC Sun Pharmaceutical Industries, Inc. 2009-09-04
53489-0479-02 50 TABLET in 1 BOTTLE, PLASTIC (53489-479-02) SULINDAC Sun Pharmaceutical Industries, Inc. 2009-09-04
53489-0479-03 250 TABLET in 1 BOTTLE, PLASTIC (53489-479-03) SULINDAC Sun Pharmaceutical Industries, Inc. 2009-09-04
53489-0479-05 500 TABLET in 1 BOTTLE, PLASTIC (53489-479-05) SULINDAC Sun Pharmaceutical Industries, Inc. 2009-09-04
53489-0479-06 60 TABLET in 1 BOTTLE, PLASTIC (53489-479-06) SULINDAC Sun Pharmaceutical Industries, Inc. 2009-09-04
53489-0479-10 1000 TABLET in 1 BOTTLE, PLASTIC (53489-479-10) SULINDAC Sun Pharmaceutical Industries, Inc. 2009-09-04
55289-0930-10 10 TABLET in 1 BOTTLE, PLASTIC (55289-930-10) Sulindac PD-Rx Pharmaceuticals, Inc. 2010-07-12
55289-0930-20 20 TABLET in 1 BOTTLE, PLASTIC (55289-930-20) Sulindac PD-Rx Pharmaceuticals, Inc. 2010-07-12
55289-0930-30 30 TABLET in 1 BOTTLE, PLASTIC (55289-930-30) Sulindac PD-Rx Pharmaceuticals, Inc. 2010-07-12
71205-0648-30 30 TABLET in 1 BOTTLE (71205-648-30) SULINDAC Proficient Rx LP 2022-03-28
71205-0648-60 60 TABLET in 1 BOTTLE (71205-648-60) SULINDAC Proficient Rx LP 2022-03-28
71205-0648-90 90 TABLET in 1 BOTTLE (71205-648-90) SULINDAC Proficient Rx LP 2022-03-28
72789-0374-01 100 TABLET in 1 BOTTLE, PLASTIC (72789-374-01) SULINDAC PD-Rx Pharmaceuticals, Inc. 2024-08-27
72789-0374-82 500 TABLET in 1 BOTTLE, PLASTIC (72789-374-82) SULINDAC PD-Rx Pharmaceuticals, Inc. 2024-01-25
Observed labelers: Sun Pharmaceutical Industries, Inc. (12) · Epic Pharma, LLC (6) · PD-Rx Pharmaceuticals, Inc. (5) · Actavis Pharma, Inc. (4) · PuraCap Laboratories LLC dba Blu Pharmaceuticals (4) · Proficient Rx LP (3) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.